Proteomic Profiling of Hepatocellular Adenomas Paves the Way to Diagnostic and Prognostic Approaches

Cyril Dourthe, Céline Julien, Sylvaine Di Tommaso, Jean‐William Dupuy, Nathalie Dugot‐Senant, Alexandre Brochard, Brigitte Le Bail, Jean‐Frédéric Blanc, Laurence Chiche, Charles Balabaud, Paulette Bioulac‐Sage, Frédéric Saltel, Anne‐Aurélie Raymond – 22 March 2021

Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study

Xinrong Zhang, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Lilian Yan Liang, Vicki Wing‐Ki Hui, Guan‐Lin Li, Henry Lik‐Yuen Chan, Grace Lai‐Hung Wong – 20 March 2021 – The benefit of colonoscopy and/or polypectomy for colorectal cancer (CRC) prevention in patients with nonalcoholic fatty liver disease (NAFLD) remains unclear. We aimed to estimate the incidence rate of CRC in patients with NAFLD who had and had not undergone colonoscopy.

A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV‐HIV Co‐infected Adults in North America

Richard K. Sterling, Wendy C. King, Mandana Khalili, Raymond T. Chung, Mark Sulkowski, Mamta K. Jain, Mauricio Lisker‐Melman, Marc G. Ghany, David K. Wong, Amanda S. Hinerman, Atul K. Bhan, Abdus S. Wahed, David E. Kleiner, the HBV‐HIV Cohort Study of the Hepatitis B Research Network – 19 March 2021

Responsible Inclusion of Pregnant Individuals in Eradicating HCV

Ravi Jhaveri, Lynn M. Yee, Swati Antala, Margaret Murphy, William A. Grobman, Seema K. Shah – 19 March 2021 – HCV infections have increased in recent years due to injection drug use and the opioid epidemic. Simultaneously, HCV cure has become a reality, with the advent of direct‐acting antivirals (DAAs) and expansion of treatment programs. As a result, HCV screening recommendations now include all adults, including pregnant individuals; and many countries have endorsed widespread DAA access as a strategy to achieve HCV eradication.

Subscribe to